RT @NatRevRheumatol: #MayIssue | Cytotoxic #Tcells contribute to vasculopathy and tissue fibrosis in diffuse cutaneous #systemicsclerosis.…
RT @NatRevRheumatol: #MayIssue | Cytotoxic #Tcells contribute to vasculopathy and tissue fibrosis in diffuse cutaneous #systemicsclerosis.…
RT @NatRevRheumatol: #MayIssue | Cytotoxic #Tcells contribute to vasculopathy and tissue fibrosis in diffuse cutaneous #systemicsclerosis.…
RT @NatRevRheumatol: #MayIssue | Cytotoxic #Tcells contribute to vasculopathy and tissue fibrosis in diffuse cutaneous #systemicsclerosis.…
RT @NatRevRheumatol: #MayIssue | Cytotoxic #Tcells contribute to vasculopathy and tissue fibrosis in diffuse cutaneous #systemicsclerosis.…
RT @NatRevRheumatol: #MayIssue | Cytotoxic #Tcells contribute to vasculopathy and tissue fibrosis in diffuse cutaneous #systemicsclerosis.…
#MayIssue | Cytotoxic #Tcells contribute to vasculopathy and tissue fibrosis in diffuse cutaneous #systemicsclerosis. Could therapeutic strategies that prevent T cell activation and cytotoxicity present an option to potentially halt disease progression? ht
RT @NatRevRheumatol: #NewsandViews | T cells in SSc skin lesions: knowing your enemy Check it out at https://t.co/eQDEAXfgeX #SystemicScl…
#NewsandViews | T cells in SSc skin lesions: knowing your enemy Check it out at https://t.co/eQDEAXfgeX #SystemicSclerosis #Scleroderma #Tcells #skin #Immunopathogenesis https://t.co/BI3k4dRl48